IP Library Assignment 069947/0405
Patent Assignment
Reel/Frame 069947/0405

Assignment of Assignor's Interest

Recorded: 2025-01-21 Pages: 19
Assignor
SORRENTO THERAPEUTICS, INC.
Executed: 2024-05-10
Assignee
VIVASOR, INC.
9380 JUDICIAL DRIVE, SAN DIEGO, CALIFORNIA, 92121
Covered Properties (2)
Transdermal Delivery of High Viscosity Bioactive Agents
Patent: 9,550,053 →
Application: 14/354,229 →
Publication: US 2014/0343532
Transdermal Delivery of High Viscosity Bioactive Agents
Application: 15/411,318 →
Publication: US 2017/0128707
Related Assignments (9)
Other recorded transfers of the patents in this record — the chain of ownership.
Name Change Feb 3, 2015
From: KIMBERLY-CLARK WORLDWIDE, INC.
To: KIMBERLY-CLARK WORLDWIDE, INC.
Reel/Frame 034880/0634 →
Assignment of Assignor's Interest Sep 18, 2018
From: KIMBERLY-CLARK WORLDWIDE, INC.
To: SORRENTO THERAPEUTICS, INC.
Reel/Frame 046899/0689 →
Assignment of Assignor's Interest Oct 24, 2018
From: ROSS, RUSSELL F.
To: KIMBERLY-CLARK WORLDWIDE, INC.
Reel/Frame 047299/0694 →
Security Interest Nov 7, 2018
From: SORRENTO THERAPEUTICS, INC.; TNK THERAPEUTICS, INC.; CONCORTIS BIOSYSTEMS, CORP.; ARK ANIMAL HEALTH, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 047446/0335 →
Release of Security Interest Jul 31, 2020
From: OAKTREE FUND ADMINISTRATION, LLC
To: SORRENTO THERAPEUTICS, INC.; TNK THERAPEUTICS, INC.; CONCORTIS BIOSYSTEMS, CORP.; ARK ANIMAL HEALTH, INC.
Reel/Frame 053368/0577 →
Security Interest Apr 6, 2023
From: SORRENTO THERAPEUTICS, INC.; SCINTILLA PHARMACEUTICALS, INC.
To: JMB CAPITAL PARTNERS LENDING, LLC
Reel/Frame 063283/0063 →
Security Interest Jul 31, 2023
From: SORRENTO THERAPEUTICS, INC.; SCINTILLA PHARMACEUTICALS, INC.
To: SCILEX HOLDING COMPANY
Reel/Frame 064441/0575 →
Release of Security Interest Aug 11, 2023
From: JMB CAPITAL PARTNERS LENDING, LLC
To: SORRENTO THERAPEUTICS, INC.; SCINTILLA PHARMACEUTICALS, INC.
Reel/Frame 064571/0848 →
Termination and Release of Security Interest in Intellectual Property Sep 21, 2023
From: SCILEX HOLDING COMPANY
To: SORRENTO THERAPEUTICS, INC.; SCINTILLA PHARMACEUTICALS, INC.
Reel/Frame 065017/0844 →